IL2 and inflammatory bowel disease: Concomitantly, TFs associated with the negative regulation of key immune pathways such as macrophage activation and MHC class II biosynthesis in UC and IL-2 production and receptor signaling via JAK-STAT in CD were predicted to lose their binding sites compared to healthy individuals due to IBD-associated SNPs (Figure S3).